| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 张林晚 | 上海证券 | 医药生物 | 42.33% | 41.15% | 30.84% | -100.00% | 1 | -18.93% | 2025-08-12 |
| 2 | 华挺 | 财通证券 | 医药生物 | 42.33% | 41.96% | 16.74% | -6.67% | 7 | -50.33% | 2025-07-31 |
| 3 | 仰佳佳 | 申万宏源 | 医药生物 | 42.32% | 44.69% | 39.86% | 23.08% | 1 | -37.64% | 2025-06-13 |
| 4 | 万鹏辉 | 国海证券 | 医药生物 | 42.32% | 33.88% | 23.07% | 50.00% | 5 | -3.00% | 2025-08-14 |
| 5 | 华挺 | 财通证券 | 医药生物 | 42.32% | 40.96% | 17.06% | -6.67% | 7 | -50.33% | 2025-08-13 |
| 6 | 刘浩 | 华创证券 | 医药生物 | 42.25% | 16.96% | -1.98% | 29.41% | 3 | -47.33% | 2024-12-31 |
| 7 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 42.17% | 43.39% | 44.63% | 12.50% | 1 | -27.10% | 2025-04-02 |
| 8 | 仰佳佳 | 申万宏源 | 医药生物 | 42.15% | 43.95% | 37.57% | 23.08% | 1 | -37.64% | 2025-06-16 |
| 9 | 华挺 | 财通证券 | 医药生物 | 42.11% | 41.74% | 16.56% | -6.67% | 7 | -50.33% | 2025-07-30 |
| 10 | 杨松 | 天风证券 | 医药生物 | 42.09% | -28.98% | 28.93% | -40.89% | 19 | -72.65% | 2025-08-04 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 42.08% | 45.19% | 31.49% | 23.08% | 1 | -37.64% | 2025-06-25 |
| 12 | 华挺 | 财通证券 | 医药生物 | 42.07% | 41.70% | 18.02% | -6.67% | 7 | -50.33% | 2025-07-29 |
| 13 | 唐寅灏 | 中信证券 | 医药生物 | 42.02% | 39.31% | 28.68% | 85.71% | 12 | -8.47% | 2025-06-24 |
| 14 | 华挺 | 财通证券 | 医药生物 | 41.94% | 25.54% | 16.41% | -6.67% | 7 | -50.33% | 2025-08-04 |
| 15 | 刘浩 | 华创证券 | 医药生物 | 41.94% | 39.12% | 41.94% | 29.41% | 1 | -47.33% | 2025-04-01 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 41.92% | 35.42% | 43.54% | 29.41% | 2 | -47.33% | 2025-05-08 |
| 17 | 华挺 | 财通证券 | 医药生物 | 41.85% | 41.00% | 16.34% | -6.67% | 7 | -50.33% | 2025-08-05 |
| 18 | 李安飞 | 广发证券 | 医药生物 | 41.84% | 35.47% | 36.83% | -2.86% | 1 | -56.96% | 2025-05-15 |
| 19 | 唐寅灏 | 中信证券 | 医药生物 | 41.80% | 29.05% | 29.96% | 85.71% | 12 | -8.47% | 2025-06-05 |
| 20 | 王斌 | 首创证券 | 医药生物 | 41.79% | 45.61% | 26.95% | 4.11% | 19 | -54.62% | 2025-07-30 |